Filing Details
- Accession Number:
- 0001127602-24-028052
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-11-26 11:06:07
- Reporting Period:
- 2024-11-22
- Accepted Time:
- 2024-11-26 11:06:07
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
920148 | Labcorp Holdings Inc. | LH | Services-Medical Laboratories (8071) | 992588107 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1805303 | B. Amy Summy | 531 South Spring Street Burlington NC 27215 | Evp, Chief Marketing Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-11-22 | 4,015 | $168.52 | 7,990 | No | 4 | M | Direct | |
Common Stock | Disposition | 2024-11-22 | 3,672 | $238.91 | 4,319 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-qualified Stock Options | Disposition | 2024-11-22 | 4,015 | $0.00 | 4,015 | $168.52 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2021-02-04 | 2030-02-03 | No | 4 | M | Direct |
Footnotes
- The price of $238.9055 per share represents a weighted average of sales prices ranging from $238.822 to $239.410 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
- Employee stock option (right to buy) granted pursuant to the Labcorp Holdings Inc. Amended and Restated 2016 Omnibus Incentive Plan.
- Represents amounts automatically adjusted based on the final adjustment ratio applied to equity awards in connection with the spin-off of Fortrea Holdings Inc. ("Fortrea") by Labcorp Holdings Inc. ("LHI"), calculated pursuant to the terms of the Employee Matters Agreement by and between LHI and Fortrea.
- The option vested in three equal annual installments beginning on the date reflected in this column.